Insights in Dolutegravir-Resistance Pathways

Thibault Mesplede; Pierre Gantner

doi:10.1093/cid/ciae127

Insights in Dolutegravir-Resistance Pathways

Thibault Mesplede
, Pierre Gantner^*

^*Corresponding author for this work

Virology

Strasbourg University Hospital
Université de Strasbourg

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

9 Downloads (Pure)

Original language	English
Pages (from-to)	1541-1542
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	79
Issue number	6
DOIs	https://doi.org/10.1093/cid/ciae127
Publication status	Published - 11 Mar 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/cid/ciae127

ciae127Final published version, 248 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{104859fc0b6d4f8c9bf8a95a87714a29,

title = "Insights in Dolutegravir-Resistance Pathways",

author = "Thibault Mesplede and Pierre Gantner",

year = "2024",

month = mar,

day = "11",

doi = "10.1093/cid/ciae127",

language = "English",

volume = "79",

pages = "1541--1542",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Insights in Dolutegravir-Resistance Pathways

AU - Mesplede, Thibault

AU - Gantner, Pierre

PY - 2024/3/11

Y1 - 2024/3/11

UR - https://www.scopus.com/pages/publications/85212781370

U2 - 10.1093/cid/ciae127

DO - 10.1093/cid/ciae127

M3 - Comment/Letter to the editor

C2 - 38462992

AN - SCOPUS:85212781370

SN - 1058-4838

VL - 79

SP - 1541

EP - 1542

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 6

ER -

Insights in Dolutegravir-Resistance Pathways

UN SDGs

Access to Document

Other files and links

Cite this